FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| Apollo Care, LLC | 71170-550 | 71170-550-25 | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | .032 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| Apollo Care, LLC | 71170-550 | 71170-550-25 | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | .032 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2025-1 | valid | 2026-10-06 | ||
| Apollo Care, LLC | 71170-550 | 71170-550-25 | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | .032 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2024-2 | valid | 2026-10-06 | ||
| Apollo Care, LLC | 71170-550 | 71170-550-25 | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride | .032 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2024-1 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2023-2 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2023-1 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2022-2 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine | .032 mg/1 mL | 2022-1 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine; Sodium Metabisulfite | .032 mg/1 mL; .064 mg/1 mL | 2021-2 | valid | 2026-10-06 | ||
| "Apollo Care, LLC(080452681)" | 71170-550 | 71170-550-25 | Norepinephrine; Sodium Metabisulfite | .032 mg/1 mL; .064 mg/1 mL | 2021-1 | valid | 2026-10-06 |